7. GVHD after MSD‐HSCT.
| Study | GVHD |
| % (N affected of N evaluable) | |
| Bayever 1984 | 51 (17 of 33)1 |
| Führer 1998 | NR |
| Gratwohl 1981 | 26 (5 of 19) |
1Bayever 1984: 51 patients with GVHD, acute or chronic. Of 35 patients receiving MSD‐HSCT, 2 were not able to develop GVHD because 1 patient died of sepsis 1 day after transplant and 1 patient experienced a graft rejection. Of 33 patients, 17 patients developed GVHD according to the results section of the article, without specifying the acute or chronic type. In the discussion section, the authors report moderate to severe GVHD in 10 patients. This could be the number of patients with acute GVHD. However, it is not clearly described how many patients had acute versus chronic GVHD.
Abbreviations: GVHD: graft‐versus‐host disease; MSD‐HSCT: first‐line allogeneic hematopoietic stem cell transplantation from HLA‐matched sibling donor; N: number; NR: not reported